Your browser doesn't support javascript.
Safety and Antibody Response After 1 and 2 Doses of BNT162b2 mRNA Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant.
Le Bourgeois, Amandine; Coste-Burel, Marianne; Guillaume, Thierry; Peterlin, Pierre; Garnier, Alice; Béné, Marie C; Chevallier, Patrice.
  • Le Bourgeois A; Hematology Department, Nantes University Hospital, Nantes, France.
  • Coste-Burel M; Virology Department, Nantes University Hospital, Nantes, France.
  • Guillaume T; Hematology Department, Nantes University Hospital, Nantes, France.
  • Peterlin P; Institut National de al Santé et de la Recherche Médicale, Unité Mixte Recherche 1232, Centre de Recherche en Cancérologie et Immunologie Nantes Angers Institut de Recherche en Santé de l'Université de Nantes, University of Nantes, France.
  • Garnier A; Hematology Department, Nantes University Hospital, Nantes, France.
  • Béné MC; Hematology Department, Nantes University Hospital, Nantes, France.
  • Chevallier P; Institut National de al Santé et de la Recherche Médicale, Unité Mixte Recherche 1232, Centre de Recherche en Cancérologie et Immunologie Nantes Angers Institut de Recherche en Santé de l'Université de Nantes, University of Nantes, France.
JAMA Netw Open ; 4(9): e2126344, 2021 09 01.
Article in English | MEDLINE | ID: covidwho-1405823
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: BNT162 Vaccine / Antibody Formation Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: JAMA Netw Open Year: 2021 Document Type: Article Affiliation country: Jamanetworkopen.2021.26344

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: BNT162 Vaccine / Antibody Formation Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: JAMA Netw Open Year: 2021 Document Type: Article Affiliation country: Jamanetworkopen.2021.26344